This finding is consistent with previous studies that have shown a correlation between VISTA and CD8 expression in various types of cancer, like HCC (75), ovarian cancer (61, 76), NSCLC (58), and triple-negative breast cancer (TNBC) (64). This evidence concerns the gene CD8A and triple-negative breast carcinoma.